Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.730
-0.011 (-1.46%)
At close: Dec 5, 2025, 4:00 PM EST
0.730
-0.000 (-0.03%)
After-hours: Dec 5, 2025, 7:38 PM EST
Xilio Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -58.49 | -58.24 | -76.4 | -88.22 | -75.8 | -55.22 | |
| Depreciation & Amortization | 1.59 | 1.64 | 1.9 | 1.85 | 1.5 | 1.07 | |
| Loss (Gain) From Sale of Assets | 0 | 0 | 0 | 0 | 0.02 | - | |
| Stock-Based Compensation | 5.53 | 6.43 | 7.38 | 8.42 | 4.96 | 1.3 | |
| Other Operating Activities | 17.71 | - | 0.16 | 0.22 | 0.38 | 0.17 | |
| Change in Accounts Payable | 1.33 | 1.53 | -2.06 | 0.49 | -2.82 | 2.93 | |
| Change in Unearned Revenue | 34.84 | 32.78 | - | - | - | - | |
| Change in Other Net Operating Assets | -2.16 | -2.52 | 0.41 | 1.52 | -8.99 | 13.68 | |
| Operating Cash Flow | -17.15 | -18.38 | -68.62 | -75.72 | -80.75 | -36.09 | |
| Capital Expenditures | -0.43 | -0.04 | -0.49 | -1.87 | -1.1 | -2.19 | |
| Investing Cash Flow | -0.43 | -0.04 | -0.49 | -1.87 | -1.1 | -2.19 | |
| Long-Term Debt Issued | - | - | - | - | 0.98 | - | |
| Long-Term Debt Repaid | - | -3.38 | -6.75 | -0.09 | -1.09 | -0.1 | |
| Net Debt Issued (Repaid) | - | -3.38 | -6.75 | -0.09 | -0.11 | -0.1 | |
| Issuance of Common Stock | 13.08 | 32.58 | 0.2 | 0.02 | 116.64 | 0.16 | |
| Other Financing Activities | 47.03 | - | - | - | -0.75 | -0.03 | |
| Financing Cash Flow | 60.11 | 29.2 | -6.55 | -0.07 | 260.67 | 10.03 | |
| Net Cash Flow | 42.53 | 10.78 | -75.66 | -77.66 | 178.82 | -28.25 | |
| Free Cash Flow | -17.58 | -18.41 | -69.11 | -77.59 | -81.85 | -38.28 | |
| Free Cash Flow Margin | -55.28% | -290.26% | - | - | - | - | |
| Free Cash Flow Per Share | -0.34 | -0.34 | -2.51 | -2.83 | -14.60 | -73.08 | |
| Cash Interest Paid | - | 0.06 | 0.57 | 0.56 | 0.49 | 0.54 | |
| Levered Free Cash Flow | -20.78 | -16.29 | -42.32 | -45.9 | -52.31 | -19.43 | |
| Unlevered Free Cash Flow | -20.72 | -16.23 | -41.88 | -45.4 | -51.94 | -19.05 | |
| Change in Working Capital | 16.5 | 31.78 | -1.66 | 2 | -11.8 | 16.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.